Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 1
2007 2
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR. Bayes M, et al. Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):569-612. Methods Find Exp Clin Pharmacol. 2005. PMID: 16273137
This issue focuses on the following selection of drugs: (-)-Epigallocatechin gallate, (Z)-4-hydroxytamoxifen; Ad.muIFN-beta AD-237, adalimumab, adefovir dipivoxil, agalsidase alfa, alemtuzumab, almotriptan, ALVAC vCP1452, alvimopan hydrate, ambrisentan, anakinra, anti-IFN-gamma M …
This issue focuses on the following selection of drugs: (-)-Epigallocatechin gallate, (Z)-4-hydroxytamoxifen; Ad.muIFN-beta AD-237, adalimum …
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR. Bayes M, et al. Methods Find Exp Clin Pharmacol. 2006 Mar;28(2):121-42. Methods Find Exp Clin Pharmacol. 2006. PMID: 16636723
This issue focuses on the following selection of drugs: 131I-labetuzumab; Abacavir sulfate, abatacept, adalimumab, ademetionine, adjuvanted influenza vaccine, alefacept, alemtuzumab, amlodipine, amphotericin B, anakinra, aripiprazole, aspirin, axitinib; Betamethasone dipropionate …
This issue focuses on the following selection of drugs: 131I-labetuzumab; Abacavir sulfate, abatacept, adalimumab, ademetionine, adjuvanted …
Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.
Liu X, De Scheerder I, Desmet W. Liu X, et al. Expert Rev Cardiovasc Ther. 2004 Sep;2(5):653-60. doi: 10.1586/14779072.2.5.653. Expert Rev Cardiovasc Ther. 2004. PMID: 15350167 Review.
Early studies using either systemic or local delivery of dexamethasone have shown limited beneficial effects on restenosis. The dexamethasone-eluting stent (Dexamet, Abbott Vascular Devices Ltd) is one of the first generation of drug-eluting stents for local drug delivery …
Early studies using either systemic or local delivery of dexamethasone have shown limited beneficial effects on restenosis. The dexamethason …
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR. Bayés M, et al. Methods Find Exp Clin Pharmacol. 2005 Sep;27(7):505-22. Methods Find Exp Clin Pharmacol. 2005. PMID: 16258596
This issue focuses on the following selection of drugs: AAV-NGFbeta, aprepitant, aripiprazole, atomoxetine hydrochloride; beta-Methyl-6-chloromelatonin, BMS-214662, bortezomib, bosentan; Calcipotriol/betamethasone dipropionate, CEA-TRICOM, cetuximab, ciclesonide, clofarabine, Cyp …
This issue focuses on the following selection of drugs: AAV-NGFbeta, aprepitant, aripiprazole, atomoxetine hydrochloride; beta-Methyl-6-chlo …
Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis.
König A, Leibig M, Rieber J, Schiele TM, Theisen K, Siebert U, Gothe RM, Klauss V. König A, et al. Am Heart J. 2007 Jun;153(6):979.e1-8. doi: 10.1016/j.ahj.2007.03.032. Am Heart J. 2007. PMID: 17540198 Clinical Trial.
In addition, statistical analysis was performed (SPSS for Windows 12.0.1). The target lesion revascularization rate was lower in the Dexamet group (10 [16.67%] vs 20 [33.33%] patients; P = .031). The QCA revealed improved lumen restoration in the Dexamet stent group …
In addition, statistical analysis was performed (SPSS for Windows 12.0.1). The target lesion revascularization rate was lower in the Dexa
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR. Bayes M, et al. Methods Find Exp Clin Pharmacol. 2007 Oct;29(8):547-83. Methods Find Exp Clin Pharmacol. 2007. PMID: 18040531
(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869, Adalimumab, Ad-rh Endostatin, AI-700, Alemtuzumab, Alvimopan hydrate, Amrubicin hydrochloride, AP-12009, Apomab 7.3, Arformoterol tartrate, Aripiprazol …
(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869, Adalimumab, …
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry.
Pesarini G, Ferrero V, Tomai F, Paloscia L, De Cesare N, Tamburino C, Piscione F, Vassanelli F, Ribichini F; Dexamethasone-Eluting Stent Italian REgistry Investigators. Pesarini G, et al. J Invasive Cardiol. 2009 Mar;21(3):86-91. J Invasive Cardiol. 2009. PMID: 19258636
This study was designed to assess the possible antiproliferative action of the Dexamet(R)dexamethasone-loaded stent. METHODS: This was a prospective, controlled registry performed in 20 Italian centers that enrolled 332 patients with acute coronary syndromes (ACS) treated …
This study was designed to assess the possible antiproliferative action of the Dexamet(R)dexamethasone-loaded stent. METHODS: This wa …
[When are drug-eluting stents effective? A critical analysis of the presently available data].
Silber S. Silber S. Z Kardiol. 2004 Sep;93(9):649-63. doi: 10.1007/s00392-004-0143-8. Z Kardiol. 2004. PMID: 15365732 Review. German.
At the time of this analysis, four DES are CE-certified and commercially available in Europe: The Cypher stent, releasing Sirolimus from a polymer (Cordis, J&J), the Taxus stent, releasing Paclitaxel from a polymer (Boston-Scientific), the V-Flex stent, releasing Paclitaxel w …
At the time of this analysis, four DES are CE-certified and commercially available in Europe: The Cypher stent, releasing Sirolimus from a p …
Inflammatory response after dexamethasone eluting coronary stent implantation.
Mut-Vitcu B, Drăgulescu SI, Drăgulescu A, El Kahlout A, Coroban A, Maximov D, Slovenski M. Mut-Vitcu B, et al. Rom J Intern Med. 2004;42(1):119-27. Rom J Intern Med. 2004. PMID: 15529601
METHODS: We investigated patients undergoing primary successful implantation of a single dexamethasone stent (Dexamet, Abbott Vascular Devices, Redwood City, CA, USA) in a native coronary artery. ...
METHODS: We investigated patients undergoing primary successful implantation of a single dexamethasone stent (Dexamet, Abbott Vascula …